These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 7250855)
21. [Analysis of the efficiency of the screening of anti-HVA IgG antibodies before active or passive immunization]. Arnal Alonso JM; Frisas Clavero O; Garuz Bellido R; Forcen Alonso T Rev Sanid Hig Publica (Madr); 1995; 69(1):71-8. PubMed ID: 7644884 [TBL] [Abstract][Full Text] [Related]
22. Recent advances in DNA vaccine of hepatitis virus. Tang LL; Liu KZ Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):228-31. PubMed ID: 14612273 [TBL] [Abstract][Full Text] [Related]
23. Medical grand rounds: frontiers in hepatitis research. Hightower MD; Texter EC J Ark Med Soc; 1980 Apr; 76(11):464-70. PubMed ID: 6445354 [No Abstract] [Full Text] [Related]
24. [Preventive vaccination for viral hepatitis]. Jilg W Z Gastroenterol; 1997 Jul; 35(7):585-90. PubMed ID: 9340933 [TBL] [Abstract][Full Text] [Related]
25. Viral hepatitis: one disease but multiple viruses. Melnick JL Dev Biol Stand; 1993; 81():3-14. PubMed ID: 8174816 [No Abstract] [Full Text] [Related]
26. [Passive and active immunoprophylaxis of hepatitis A. New vaccines]. Grzeszczuk A Przegl Epidemiol; 1997; 51(4):417-24. PubMed ID: 9562789 [TBL] [Abstract][Full Text] [Related]
27. [What is assured in therapy of chronic viral hepatitis?]. Manns MP; Böker KH Internist (Berl); 1993 Dec; 34(12):1096-106. PubMed ID: 8106205 [No Abstract] [Full Text] [Related]
28. Prevention of viral hepatitis in Italy. FitzSimons D; François G; Bonanni P; Mele A; Zanetti A; Stroffolini T; Crovari P; Van Damme P Vaccine; 2004 Sep; 22(29-30):4092-6. PubMed ID: 15364461 [TBL] [Abstract][Full Text] [Related]
29. ACIP issues recommendations for hepatitis A prevention with active or passive immunization. Advisory Committee on Immunization Practices. Am Fam Physician; 1997 Feb; 55(3):973-6. PubMed ID: 9048511 [No Abstract] [Full Text] [Related]
30. Viral hepatitis, a public health overview. St Amant CP J Med Assoc State Ala; 1982 Jul; 52(1):11-3, 17-8. PubMed ID: 7108400 [No Abstract] [Full Text] [Related]
32. Office-based approach to the implementation of a hepatitis immunization program. Peterson DC; Palevsky SL Am J Med; 2005 Oct; 118 Suppl 10A():90S-9S5. PubMed ID: 16271548 [TBL] [Abstract][Full Text] [Related]
33. [Prevention, diagnostics and treatment of virus hepatitis]. Lappalainen M; Meurman O; Färkkilä M Duodecim; 2000; 116(1):61-9. PubMed ID: 11764462 [No Abstract] [Full Text] [Related]
34. Cost-effective analysis of hepatitis A prevention in Ireland. Rajan E; Shattock AG; Fielding JF Am J Gastroenterol; 2000 Jan; 95(1):223-6. PubMed ID: 10638588 [TBL] [Abstract][Full Text] [Related]
35. [Prevention of viral hepatitis. Vaccination against hepatitis B virus]. Pillot J Rev Prat; 1981 Dec; 31(59):4259-60, 4263-6. PubMed ID: 7323638 [No Abstract] [Full Text] [Related]
36. Anti-hepatitis A antibody titers after passive immunization with hepatitis A hyperimmune globulin. Poovorawan Y; Theamboonlers A; Vimolkej L; Cryz SJ Southeast Asian J Trop Med Public Health; 1995 Mar; 26(1):193-4. PubMed ID: 8525412 [No Abstract] [Full Text] [Related]
37. Hepatitis A: from epidemic jaundice to a vaccine-preventable disease. Levinthal G; Ray M Gastroenterologist; 1996 Jun; 4(2):107-17. PubMed ID: 8792141 [TBL] [Abstract][Full Text] [Related]
38. [Hepatitis vaccination of adults]. Jost R Schweiz Med Wochenschr; 1998 Jul; 128(27-28):1104-9. PubMed ID: 9691345 [TBL] [Abstract][Full Text] [Related]
39. [Passive immunization against hepatitis B: state of development, comments and recommendations for clinical use]. Scheiermann N; Kuwert EK Fortschr Med; 1980 Jan; 98(2):39-45. PubMed ID: 7364355 [TBL] [Abstract][Full Text] [Related]
40. Migration: public health issues (polio, hepatitis A, hepatitis B, tuberculosis, diphtheria). Schwanig M Biologicals; 1997 Jun; 25(2):187-93. PubMed ID: 9236050 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]